Bavar­i­an Nordic nets ma­jor vac­cine con­tract to re­spond to mon­key­pox out­break

The cur­rent mon­key­pox out­break is now at a phase where some gov­ern­ments are ap­proach­ing a point of con­cern, at least enough to start stock­pil­ing vac­cines.

In re­sponse, at least one gov­ern­ment is plac­ing its or­der with vac­cine man­u­fac­tur­er Bavar­i­an Nordic to se­cure suf­fi­cient sup­ply for vac­ci­nat­ing in­di­vid­u­als. Ac­cord­ing to the com­pa­ny, it has inked a sup­ply con­tract with an undis­closed coun­try for the com­pa­ny’s small­pox vac­cine, called Jyn­neos. The aim is to en­sure there will be enough sup­ply to meet the undis­closed coun­try’s re­quire­ments for vac­ci­nat­ing in­di­vid­u­als at risk for mon­key­pox in the short to medi­um term. The vac­cine is ap­proved for use against mon­key­pox by the FDA and Health Cana­da.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER